The Wait Is Over

Nearly 32 million people worldwide have had LASIK to date.7 They are the tip of the iceberg, as industry experts estimate that there are as many as 290 million additional candidates worldwide. Helping you tap this vast potential market is the ultimate objective of AMO® in introducing the iLASIK™ procedure. To accomplish this, we will use the iLASIK brand as a catalyst for a new kind of marketing conversation. We'll help you reach out to "Generation i" — the dynamic group of prospects spanning Generation Y, Generation X and Baby Boomers — by speaking their language and taking the mystery and confusion out of laser vision correction.

"Generation i" has been waiting for the iLASIK procedure.

Generation Y (21-29)

  • Experiencing financial independence for the first time, Generation Y is online in huge numbers and has huge potential buying clout; no laser company has ever talked to them directly about laser eye surgery
  • The iLASIK platform will enable you to capitalize on the Generation Y opportunity

Generation X (30-39)

  • They've grown up with LASIK, but still don't understand it; they're waiting for the next "big thing"
  • With the iLASIK procedure, their wait is over; now they will finally understand the basis of laser eye surgery

Baby Boomers (40+)

  • Safety is a main concern; they're dealing with presbyopia; they want the best technology
  • The iLASIK suite has an outstanding safety profile; it is approved for monovision in presbyopic patients with myopia and provides the broadest range of custom wavefront-guided laser correction

Laser assisted in-situ keratomileusis (LASIK) can only be performed by a trained physician and is specified for reduction or elimination of myopia, hyperopia, and astigmatism as indicated within the product labeling. Laser refractive surgery is contraindicated for patients: a) with collagen vascular, autoimmune, or immunodeficiency diseases; b) who are pregnant or nursing women; c) with signs of keratoconus or abnormal corneal topography; d) who are taking one or both of the following medications: Isotretinoin (Accutane) and Amiodarone hydrochloride (Cordarone). Potential side effects to laser refractive surgery may include glare, dry eye, as well as other visual anomalies. LASIK requires the use of a microkeratome that cuts a flap on the surface of the cornea, potential side effects may include flap related complications. Consult with your eye care professional and Patient Information Booklet regarding the potential risks and benefits for laser refractive surgery, results may vary for each individual patient.

Restricted Device: U.S. Federal Law restricts this device to sale, distribution, and use by or on the order of a physician or other licensed eye care practitioner. U.S. Federal Law restricts the use of this device to practitioners who have been trained in its calibration and operation and who have experience in the surgical treatment and management of refractive errors.